Other
Drug Facts
Distributed by:
Reckitt Benckiser
Parsippany, NJ 07054-0224
© 2012 RB
The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Mucinex D (NDC 50090-1076). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - purpose, uses, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Distributed by:
Reckitt Benckiser
Parsippany, NJ 07054-0224
© 2012 RB
| Active ingredients (in each extended-release bi-layer tablet) | Purpose |
| Guaifenesin 600 mg | Expectorant |
| Pseudoephedrine HCl 60 mg | Nasal Decongestant |
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Carbomer homopolymer type B; FD&C yellow #6 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639) You may also report side effects to this phone number.
Product: 50090-1076
NDC: 50090-1076-0 9 TABLET, EXTENDED RELEASE in a BLISTER PACK
* Please review the disclaimer below.